Pirfenidone attenuates acetaminophen-induced liver injury via suppressing c-Jun N-terminal kinase phosphorylation
Shigeki Tashiro(Kyushu University), Yoshihiro Ogawa(Kyushu University)
Cited by 15
Related Papers
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
|PLoS ONE|2016|229
Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis
|Nature Communications|2014|196
Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH
|Scientific Reports|2018|174
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
|Scientific Reports|2018|86
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
|Scientific Reports|2017|64